The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Kaysen David B since year 2005.
The trader's CIK number is 1133026.
At the time of this reporting, Kaysen David B is the President and CEO of Sun Biopharma, Inc. .
(stock ticker symbol SNBP).
See this page for all insider trading activities at Sun Biopharma, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-05-16||SNBP||Sun Biopharma, Inc.||Buy||1,000||.00||0|
|2016-06-24||SNBP||Sun Biopharma, Inc.||Buy||50,000||.00||0|
|2006-05-11||ZVXI||Zevex International Inc||Sale||17,580||23.26||408,910|
|2006-05-11||ZVXI||Zevex International Inc||Option Ex||17,580||3.61||63,463|
|2006-03-05||ZVXI||Zevex International Inc||Sale||7,420||15.13||112,264|
|2006-03-05||ZVXI||Zevex International Inc||Option Ex||7,420||2.65||19,685|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kaysen David B (President and CEO of Sun Biopharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.